Log In/Sign Up Become a Member Submit an Idea
Search

Accelerate Late-Stage R&D

Resource Tag: Accelerate Late-Stage R&D

Implementing Blockchain Applications in Healthcare

Blockchain technology can revolutionise the way information is exchanged between parties by bringing an unprecedented level of security and trust to these transactions. The technology is finding its way into multiple use cases but we are yet to see full adoption and real-world business implementation in the Healthcare industry. In this webinar we will explore the main challenges and considerations for the implementation of Blockchain technology in Healthcare use cases.

This is the third webinar in our Blockchain Education series. Our speakers belong to the wide Blockchain community and are responsible for driving innovation in the Life Sciences and Healthcare industries.

So That’s What a Blockchain Is! An In-Depth Introduction

In preparation for Pistoia Alliance’s Blockchain Bootcamp, with our friends from the Fraunhofer institute, learn about of the underlying technology, the current uses of blockchain in other industries, and when blockchain is appropriate for various use-cases, followed by a demo.

tranSMART: Our History Webpage

In May 2017, i2b2 and tranSMART Foundations merged to integrate the two leading information and analysis platforms that are used in the clinical and translational research to advance precision medicine around the globe.

Text Mining for Pharma R&D in a Social World

Text-mining of journal articles and other publications has long been a subject of interest. It already has applications across R&D and beyond into health care, for instance by analysing electronic health records. The technology has value but also has its limits. With new sources of text to mine becoming mainstream, such as Twitter feeds or Facebook posts that might reference a company’s brand or a drug’s efficacy or adverse events, existing technology needs to be adapted to keep pace. Not only that, but whole new compliance questions arise: does a fleeting mention on Twitter require the same response as a formal notification of an adverse event?